In Japan, Pfizer Is Short of Drug to Help Smokers

In Japan, Pfizer Is Short of Drug to Help Smokers

The tax increase should also have been a bonanza for Pfizer, the world’s biggest pharmaceutical company, which makes the leading drug to help smokers break the habit.

Instead, it became a missed opportunity.

Despite ample notice of the change, Pfizer failed to produce enough of the drug, Chantix, which is sold as Champix in Japan. When tens of thousands of would-be quitters rushed to their doctors for prescriptions, Pfizer was overwhelmed.

 禁煙外来保険ききますからね。やっぱりたばこ増税もビジネスチャンスなんだなぁ。